Jacqueline B. Vo, PhD, RN, MPH, FAAN joined the Nell Hodgson Woodruff School of Nursing at Emory University as a Tenure-Track Assistant Professor in 2026. Dr. Vo is trained as a nurse scientist and clinical epidemiologist, with a research program focused on the adverse effects of cancer treatment on cardiovascular disease and subsequent malignancy risks and on how cancer outcomes differ across different populations, most notably for disaggregated Asian American and Pacific Islander populations. 

Dr. Vo obtained a Bachelor of Science in Nursing (2014) and Doctor of Philosophy (2018) at the University of Alabama at Birmingham (UAB) and a Master of Public Health (2019) with a focus in quantitative methods at Harvard T.H. Chan School of Public Health. During her doctoral training, Dr. Vo was a Robert Wood Johnson Future of Nursing Scholar and Susan G. Komen Graduate Trainee in Disparities Research, and she received the American Cancer Society Doctoral Degree Scholarship in Cancer Nursing. Dr. Vo also received the Dean’s Award and was the 2018 Commencement Speaker for the UAB Doctoral Hooding. At the National Cancer Institute (NCI)/National Institutes of Health (NIH), Dr. Vo was a Postdoctoral Fellow in the Cancer Prevention Fellowship Program from 2018-2022, Assistant Clinical Investigator from 2022-2024, and Tenure-Track Investigator from 2024-2025. She received the Merit Award, Director’s Award for Mentoring and Emerging Leader, and received the NIH Distinguished Scholar Award. At NCI, Dr. Vo co-led the NCI-Kaiser Permanente Breast Cancer Survivors Cohort, a retrospective cohort of ~30,000 breast cancer survivors across 4 centers nationally linking data from cancer registries, medical records, claims and prescription data, and vital statistics. As a devoted nurse-epidemiologist, Dr. Vo’s conducts emerging research that has high potential for translating back to the clinical setting to improve the lives of cancer patients.

Vo, J.B., Brandt, C., Taparra, K., Ramin, C., Berrington de Gonzalez, A., Gierach, G.L., Lawrence, W.R., Rhee, J., Shiels, M.S., Veiga, L.H.S., Mitra, P., Shing, J.Z., Yi, S.S. (2025). Disparities in heart disease mortality among Asian American and Pacific Islander breast cancer survivors. JACC: CardioOncology. https://doi.org/10.1016/j.jaccao.2025.08.003

Shing, J.Z., Mitra, P., Freedman, N.D., Taparra, K., DeVille, N.V., Bess, J.L., Madrigal, J.M., Berrington de Gonzalez, A., Shiels, M., Vo, J.B. (2025). County-level factors and mortality among Pacific Islander vs Asian American adults. JAMA Network Open.  doi: 10.1001/jamanetworkopen.2025.14248 PMID: 40478573

Vo, J.B., Bess, J. , Taparra, K., Mitra, P., Berrington de Gonzalez, A., Freedman, N.D., Shiels, M.S., Shing, J.Z. (2025). Leading causes of death among Asian American compared with Pacific Islander individuals. JAMA Internal Medicine. doi:10.1001/jamainternmed.2024.6487

Bloom, M.W, Vo, J.B., Rodgers, J.E., Ferrari, A.M., Nohria, A., Deswal, A., Cheng, R.K., Kittleson, M.M., Upshaw, J.N., Palaskas, N., Blaes, A., Brown, S.A., Ky, B., Lenihan, D., Maurer, M.S., Fadol, A., Skurka, K., Cambareri, C., Chauhan, C., & Barac, A. (2025). Cardio-Oncology and Heart Failure: A Scientific Statement from the Heart Failure Society of America. Journal of Cardiac Failure. 31(2):415-455. doi: 10.1016/j.cardfail.2024.08.045

Vo, J.B., Ramin, C., Veiga, L.H.S., Brandt, C., Curtis, R.E., Bodelon, C., Barac, A., Roger, V., Feigelson, H.S., Bowles, E.J.A., Buist, D.S.M., Gierach, G., & Berrington de Gonzalez, A. (2024). Long-term cardiovascular disease risk after chemotherapy among U.S. breast cancer survivors. Journal of the National Cancer Institute. doi:10.1093/jnci/djae107

Veiga, L.H.S., Vo, J.B., Curtis, R.E., Mille, M.M., Lee, C., Ramin, C., Bodelon, C., Bowles, E.J.A., Buist, D.S.M., Weinmann, S., Feigelson, H.S., Gierach, G., Berrington de Gonzalez, A. (2022). Treatment-related thoracic soft tissue sarcomas in two retrospective cohorts of US breast cancer survivors. Lancet Oncology. https://doi.org/10.1016/S1470-2045(22)00561-7 PMCID: PMC9633446

Ho, K., Shiels, M., Ramin, C., Veiga, L., Chen, Y., Berrington de Gonzalez, A., Vo, J.B. (2022). County-level socioeconomic and rural disparities in cardiovascular disease mortality among US breast cancer survivors, 2000-2018. Journal of the National Cancer Institute Cancer Spectrum. doi:0.1093/jncics/pkac083 PMCID: PMC9901273

Shing, J.Z., Corbin, J., Kreimer, A., Carvajal, L.J., Taparra, K., Shiels, M., & Vo, J.B. (2023). Incidence of HPV-associated cancers among disaggregated Asian American and Pacific Islander ethnogeographic region and ethnicity. Journal of the National Cancer Institute Cancer Spectrum. doi: 10.1093/jncics/pkad012 PMCID: PMC10017119

Vo, J.B., Ramin, C., Lawrence, W., Barac, A., Ho, K.L., Rhee, J., Veiga, L., & Berrington de Gonzalez, A. (2023). Racial and ethnic disparities in treatment-related heart disease mortality among US breast cancer survivors. Journal of the National Cancer Institute Cancer Spectrum. doi: 10.1093/jncics/pkad024. PMCID: PMC10130190

Vo, J.B., Ramin, C., Barac, A., Berrington de Gonzalez, A., & Veiga, L. (2022). Trends in heart disease mortality among breast cancer survivors in the USA, 1975-2017. Breast Cancer Research and Treatment, 192(3):611-622. doi: 10.1007/s10549-022-06515-5. PMCID: PMC8960573

‍

Complete List of Published Work in MyBibliography: https://www.ncbi.nlm.nih.gov/myncbi/jacqueline%20b..vo.1/bibliography/public/

Dr. Vo is deeply passionate about mentoring the next generation of nurses, nurse-scientists, and epidemiologists. She teaches public and population health nursing for prelicensure nursing students and mentors undergraduate and pre- and post-doctoral trainees through the full continuum of scientific inquiry—from identifying meaningful clinical questions, designing epidemiologic studies, applying analytic methods to answer research questions, to disseminating findings that improve the lives of patients. Dr. Vo fosters building confidence, critical thinking, independence, and resilience in her trainees to have success with scholarly writing and clear research communication. Her trainees have published in high impact journals, started their first job or entered graduate school, and achieved numerous awards.

Dr. Vo’s research interests center on studying the intersection between cancer and cardiovascular disease. Cardiovascular disease is a growing public health concern for cancer survivors due to treatment-related cardiotoxicity and shared risk factors. Cancer treatments, such as chest irradiation, anthracycline-based chemotherapy, trastuzumab, and endocrine therapy, are associated with increased risks of cardiotoxicity. Breast cancer survivors comprise the largest population of cancer survivors and experience increased cardiovascular disease risk compared to the general population. Dr. Vo studies treatment-related cardiovascular disease by leveraging data from SEER, SEER-Medicare, national vital statistics, and the NCI-Kaiser Permanente Breast Cancer Survivors Cohort. To better understand risk factors associated with subsequent malignancies, Dr. Vo has an interest in studying the intersection of treatment and comorbidities including cardiovascular disease on the risk of second primary cancers among cancer survivors. Dr. Vo is also interested in quantifying health differences by race and ethnicity or socioeconomic status among different cancer survivor populations. Dr. Vo has a special emphasis on the disaggregation of Asian American and Pacific Islander populations, who comprise two distinct and diverse racial groups with varying immigration or colonization experiences, socioeconomic status, and cancer burden. Dr. Vo has led the expansion of the NCI-Kaiser Permanente Breast Cancer Survivors Cohort to include a more geographically and racially diverse cohort and to link to area-level socioeconomic status and rurality attributes. Through these expansions, Dr. Vo studies the relationships between neighborhood-level socioeconomic status, which may influence treatment access or barriers, and treatment-related outcomes on treatment-related cardiovascular disease, second cancers, and mortality. Her studies can better inform clinical decision-making on treatment risks and benefits and improve the quality of life of cancer survivors.

‍

• Fellow, American Academy of Nursing
• Distinguished Scholar, National Institutes of Health
• Merit Award, National Cancer Institute, National Institutes of Health
• Director's Award, Champion Award for Outstanding Mentor, National Cancer Institute, National Institutes of Health
• Director's Award, Champion Award for Emerging Leader, National Cancer Institute, National Institutes of Health
• Scholar-In-Training, American Association of Cancer Research
• Best of ASPO: Breast Cancer, American Society of Preventive Oncology
• Dean’s Award, University of Alabama at Birmingham School of Nursing
• Future of Nursing Scholar, Robert Wood Johnson Foundation